Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)
Clinical trial NCT04227327 · TERMINATED
Trial details
- NCT number
- NCT04227327
- Sponsor
- University of Milano Bicocca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-07
- Primary completion
- 2024-07-25
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.